53
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Antisecretory Effect of Loperamide in Colon Epithelial Cells by Inhibition of Basolateral K+ Conductance

Pages 731-737 | Published online: 08 Jul 2009
 

Abstract

Background: The mechanism of the antisecretory effect of loperamide was investigated in cultured highly differentiated colon epithelial cells (HT-29/B6). Methods: Chloride secretion was stimulated via cAMP by forskolin (FSK, 10-5 M), via Ca2+ by the muscarinic agonist carbachol (CCh, 10-4 M), and via protein kinase C by the phorbol ester PMA (5·10-9 M). Stimulated Cl- secretion was quantified as short circuit current (ISC) of HT-29/B6 monolayers mounted in Ussing-type chambers. Results: Loperamide (5·10-5 M) inhibited ISC stimulated by FSK, CCh and PMA. The antisecretory action of loperamide was unaffected by preincubation with naloxone (10-5 M). Furthermore, loperamide strongly inhibited basolateral 86Rb efflux. Like loperamide, the calmodulin antagonist trifluoperazine (10-4 M) inhibited ISC induced by FSK, CCh or PMA. The Ca2+ channel blocker verapamil (5·10-5 M), on the other hand, inhibited only PMA-stimulated ISC, but had no effect on FSK or CCh-induced ISC. Conclusions: Loperamide exerts a direct antisecretory action on chloride secretion of colon epithelial cells independently of the respective stimulatory signal transduction pathway. This antisecretory effect is not mediated by opiate receptors and reflects inhibition of basolateral K+ conductance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.